The Impact of Follow-up Examination Recommendation Notices after Health Check-ups on Behaviour towards Re-examination: A Non-randomised Intervention Study Targeting Individuals Suspected of Having Hypertension, Glucose Metabolism Disorders and Dyslipidemia
Health Evaluation and Promotion · 2026
DOI: 10.7143/jhep.2025-55 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Evaluation and Promotion, 2026. Verfasst von Miki Ishii und 10 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ishii, M., Suzuki, M., Fujiwara, F., Ozawa, H., Shimada, Y., Kamakita, I., Inoue, I., Yamanouchi, Y., Gotou, S., Maruyama, Y., & Muramatsu, T. (2026). The Impact of Follow-up Examination Recommendation Notices after Health Check-ups on Behaviour towards Re-examination: A Non-randomised Intervention Study Targeting Individuals Suspected of Having Hypertension, Glucose Metabolism Disorders and Dyslipidemia. Health Evaluation and Promotion. https://doi.org/10.7143/jhep.2025-55
Vancouver
Ishii M, Suzuki M, Fujiwara F, Ozawa H, Shimada Y, Kamakita I, et al. The Impact of Follow-up Examination Recommendation Notices after Health Check-ups on Behaviour towards Re-examination: A Non-randomised Intervention Study Targeting Individuals Suspected of Having Hypertension, Glucose Metabolism Disorders and Dyslipidemia. Health Evaluation and Promotion. 2026. doi:10.7143/jhep.2025-55
BibTeX
@article{Ishii2026,
author = {Ishii, Miki and Suzuki, Manami and Fujiwara, Fumiko and Ozawa, Hisako and Shimada, Yoshiko and Kamakita, Ikuko and Inoue, Ikuo and Yamanouchi, Yoko and Gotou, Seiichi and Maruyama, Yoshiaki and Muramatsu, Toshihiro},
title = {The Impact of Follow-up Examination Recommendation Notices after Health Check-ups on Behaviour towards Re-examination: A Non-randomised Intervention Study Targeting Individuals Suspected of Having Hypertension, Glucose Metabolism Disorders and Dyslipidemia},
journal = {Health Evaluation and Promotion},
year = {2026},
doi = {10.7143/jhep.2025-55}
}
EUVIMED